Cargando…
mTOR and Tumor Cachexia
Cancer cachexia affects most patients with advanced forms of cancers. It is mainly characterized by weight loss, due to muscle and adipose mass depletion. As cachexia is associated with increased morbidity and mortality in cancer patients, identifying the underlying mechanisms leading to cachexia is...
Autores principales: | Duval, Adrian P., Jeanneret, Cheryl, Santoro, Tania, Dormond, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121479/ https://www.ncbi.nlm.nih.gov/pubmed/30061533 http://dx.doi.org/10.3390/ijms19082225 |
Ejemplares similares
-
Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy
por: Faes, Seraina, et al.
Publicado: (2017) -
mTOR in Human Diseases
por: Dormond, Olivier
Publicado: (2019) -
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
por: el Hage, Alexandre, et al.
Publicado: (2021) -
Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives
por: Dufour, Marc, et al.
Publicado: (2011) -
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells
por: Blaser, Benjamin, et al.
Publicado: (2012)